๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of Study BCB111 is to collect efficacy, pharmacokinetic, pharma...
Status
Completed
Location
Research Site
Start Date
2010-05
Trial ID
NCT01104701
The aim of this study is to assess the long-term safety of exenatide in pat...
Status
Completed
Location
Research Site
Start Date
2003-12
Trial ID
NCT01876849
Treatments Being Tested
Cross-sectional, single-centre, 'low intervention' clinical study, without ...
Status
Recruiting
Location
Azienda Ospedaliero-Universitaria di Parma
Start Date
2024-10-14
Trial ID
NCT06888167
Treatments Being Tested
This is a retrospective cohort study of patients with T2DM who were treated...
Status
Recruiting
Location
China, Jiangsu, Department of Endocrinology
Start Date
2024-01-01
Trial ID
NCT06256419
Treatments Being Tested
Phase 3 study to examine treatment with ITCA 650 compared to glimepiride wh...
Status
Withdrawn
Location
Intarcia Therapeutics, Inc
Start Date
2013-02
Trial ID
NCT01455883
Treatments Being Tested
Polycystic ovary syndrome (PCOS) is a health problem that affects one in 10...
Status
Completed
Location
The Second Affiliated Hospital, Third Military Medical University
Start Date
2017-07-01
Trial ID
NCT03151005
Treatments Being Tested
Phase 3 study to examine treatment with ITCA 650 compared to glimepiride wh...
Status
Withdrawn
Location
Intarcia Therapeutics, Inc
Start Date
2013-02
Trial ID
NCT01455922
Treatments Being Tested
People with type 2 diabetes experience heart failure more often than do peo...
Status
Terminated
Location
Baylor College of Medicine
Start Date
2009-07
Trial ID
NCT00799435
Treatments Being Tested
Whether GLP-1 receptor agonists sequential therapy in newly diagnosed type ...
Status
Unknown
Location
Xiaolong Zhao
Start Date
2014-02
Trial ID
NCT02129985
The primary purpose of this study is to assess the anti-exenatide-antibody ...
Status
Completed
Location
Research Site
Start Date
2007-08
Trial ID
NCT00516048
Treatments Being Tested